Hypergraph geometry localizes mutation-associated dependency vulnerabilities in cancer.
The paper identifies mutation-associated therapeutic vulnerabilities in cancer using hypergraph geometry and CRISPR screens, finding specific dependencies with drug sensitivity.
bioRxiv · Jul 29, 2026 · PreprintBioinformatics